Seaport Therapeutics, Inc. Common Stock

NASDAQ:SPTX

Biotechnology

Healthcare
$18.31 +0.58%

+$0.10 today

Market cap
$980.14M
Beta
0.00
52W Low $14.85High $23.00

Volume 0.68M

Average 0.41M

SPTX Stock-Based Compensation

Employee pay granted in shares or options; a non-cash expense that dilutes existing shareholders.

No reported Stock-Based Compensation figures are available to summarize.

Stock-Based Compensation history

Currency unavailable · from the cash flow

No Stock-Based Compensation data reported for this period type.

Stock-Based Compensation vs competitors

How SPTX compares with its peers on the latest reported figures

SPTX Competitors
Stock-Based Compensation for SPTX and competitors
Company Period LTM YoY 3-year CAGR% of revenue
NMRANeumora Therapeutics, Inc. Common StockLTM Mar 2026$27.96M USD-33.3%+53.3%—
RAPPRapport Therapeutics, Inc. Common StockLTM Mar 2026$21.78M USD+70.4%+213.9%108.9%
CTNMContineum Therapeutics, Inc. Class A Common StockLTM Mar 2026$11.29M USD+31.2%+73.3%—
VNDAVanda Pharmaceuticals Inc.LTM Mar 2026$9.07M USD-23.3%-16.5%4.2%
GHRSGH Research PLCLTM Mar 2026$1.88M USD-32.3%——
LBRXLB Pharmaceuticals Inc Common StockLTM Mar 2026$1.37M USD———
MPLTMapLight Therapeutics, Inc.LTM Mar 2026$125K USD-78.0%——
SPTXSeaport Therapeutics, Inc. Common Stock—— ———
Peer median (excluding SPTX) —-27.8%+63.3%56.5%

Competitors are the stored peer set for SPTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Seaport Therapeutics, Inc. Common Stock

NASDAQ:SPTX

Intrinsic Alpha fair value

Locked

Current Price

$18.31

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.